Suppression of viability and acetyl-LDL metabolism in Raw 264 macrophage-like and smooth muscle cells by bisphosphonates in vitro

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 24, Issue 8, 2002, Pages 487-492

  Tuominen, O M ^a   Hollmen M ^a   Jaakkola, O ^a   Monkkonen J ^b   Ylitalo, Ritva ^a,c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Atherosclerosis; Bisphosphonates; Low density liporotein (LDL); Macrophages; Smooth muscle cells

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CHOLESTEROL; CLODRONIC ACID; DISTEAROYLPHOSPHATIDIC ACID; ETIDRONIC ACID; IODINE 125; LIPOSOME; TILUDRONIC ACID;

ANIMAL CELL; ARTERY MUSCLE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL METABOLISM; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG UPTAKE; ENCAPSULATION; IN VITRO STUDY; LIPOPROTEIN METABOLISM; MACROPHAGE; MOUSE; NONHUMAN; RABBIT;

ANIMALS; AORTA; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; DIPHOSPHONATES; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; GROWTH INHIBITORS; HUMANS; LIPOPROTEINS, LDL; LIPOSOMES; MACROPHAGES; MICE; MUSCLE, SMOOTH, VASCULAR; PHAGOCYTOSIS; RABBITS;

EID: 0036814540     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2002.24.8.705068     Document Type: Article

References (29)

1. Fleisch, H. Bisphosphonates: Pharmacology and use in the treatment of tumor-induced hypercalcaemic and metastatic bone diseases. Drugs 1991, 42: 919-44.
2. Ross, R. The pathogenesis of atherosclerosis - A perspective for the 1990s. Nature 1993, 362: 801-9.
3. Rosenblum, I.Y., Flora, L., Eisenstein, R. The effect of disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP) on a rabbit model of athero-arteriosclerosis. Atherosclerosis 1975, 22: 411-24.
4. Kramsch, D.M., Chan, C.T. The effect of agents interfering with soft tissue calcification and cell proliferation on calcific fibrous-fatty plaques in rabbits. Circ Res 1978, 42: 562-72.
5. Kramsch, D.M., Aspen, A.J., Rozter, L.J. Atherosclerosis: Prevention by agents not affecting abnormal levels of blood lipids. Science 1981, 213: 1511-3.
6. Ylitalo, R., Oksala, O., Ylä-Herttuala, S., Ylitalo, P. Effects of clodronate (dichloromethylene bisphosphonate) on the development of experimental atherosclerosis in rabbits. J Lab Clin Med 1994, 123: 769-76.
7. Koshiyama, H., Nakamura, Y., Tanaka, S., Minamikawa, F. Decrease in carotid intima-media thickness after 1-year therapy with etidronate for osteopenia associated with type 2 diabetes. J Clin Endocr Metab 2000. 85: 2793-6.
8. Ylitalo, R. Bisphosphonates and atherosclerosis. Gen Pharmacol 2002, 35: 287-96.
9. Ylitalo, R., Mönkkönen, J., Urtti, A., Ylitalo, P. Accumalation of bisphosphonates in the aorta and some other tissues of healthy and atherosclerotic rabbits. J Lab Clin Med 1996, 127: 200-6.
10. Ylitalo, R., Kalliovalkama, J., Wu, X. et al. Accumulation of bisphosphonates in human artery and their effects on human and rat arterial function in vitro. Pharmacol Toxicol 1998, 83: 125-31.
11. Schaffner, T., Taylor, K., Bartucci, E.J. et al. Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. Am J Pathol 1980, 100: 57-80.
12. Gerrity, R.H. The role of the monocyte in artherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 1981, 103: 181-90.
13. Ylitalo, R., Mönkkönen, J., Ylä-Herttuala, S. Effects of liposome-encapsulated bisphosphonates on acetylated LDL metabolism, lipid accumulation and viability of phagocyting cells. Life Sci 1998, 62: 413-22.
14. Ylitalo, R., Jaakkola, O., Lehtolainen, P., Ylä-Herttuala, S. Metabolism of modified LDL and foam cell formation in murine macrophage-like RAW 264 cells. Life Sci 1999, 64: 1955-65.
15. Benford, H.L., Frith, J.C., Auriola, S., Mönkkönen J. Rogers M.J. Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: Biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs. Mol Pharm 1999, 56: 131-40.
16. Rogers, M.J., Gordon, S., Benford, H.L. et al. Cellular and molecular mechanisms of action of bisphosphonates. Cancer 2000, 88: 2961-78.
17. Jaakkola, O., Solakivi, T., Ylä-Herttuala S., Nikkari, T. Receptor-mediated binding and degradation of subfractions of human plasma low density lipoprotein by cultured fibroblasts. Biochim Biophys Acta 1989, 1005: 118-22.
18. Salacinski, P.R., McLean, C., Sykes, J.E., Clement-Jones, V.V., Lowry P.J. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha, 6 alpha-diphenyl glycoluril (Iodogen). Anal Biochem 1981, 117: 136-46.
19. Basu, S.K., Brown, M.S., Ho, Y.K., Goldstein, J.L. Degradation of low density lipoprotein dextran sulfate complexes associated with deposition of cholesteryl esters in mouse macrophages. J Biol Chem 1979, 254: 7141-6.
20. Mönkkönen, J., Taskinen, M., Auriola S.O., Urtti, A. Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound and free bisphosphonates in vitro. J Drug Target 1994, 2: 299-308.
21. Peterson, G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977, 83: 346-56.
22. Bierman, E.L., Stein, O., Stein, Y. Lipoprotein uptake and metabolism by rat aortic smooth muscle cells in tissue culture. Circ Res 1974, 35: 136-50.
23. Chambers, T.J. Diphosphonates inhibit bone resorption by macrophages in vitro. J Pathol 1980, 132: 255-62.
24. Reitsma, P.H., Teitelbaum, S.L., Bijvoet, O.L., Kahn, A.J. Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (C12MDP) on rat macrophage bisphosphotiate (C12MDP) on rat inacrolihage-mediated bone resorption in vitro. J Clin Invest 1982, 70: 927-33.
25. Stevenson, P.H., Stevenson, J.R. Cytotoxic and migration inhibitory effects of bisphosphonates on macrophages. Calcif Tissue Int 1986, 38: 227-33.
26. Ito, M., Chokki, M., Ogino, Y. et al. Comparison of cytotoxic effects of bisphosphonates in vitro and in vivo. Calcif Tissue Int 1998, 63: 143-7.
27. Kockx, M.M., Herman, A.G. Apoptosis in atherosclerosis: Beneficial or detrimental? Cardiovasc Res 2000, 45: 736-46.
28. Ylitalo, R., Syvälä, H., Tuohimaa, P., Ylitalo, P. Suppression of immunoreactive macrophages in atheromatous lesions of rabbits by clodronate. Pharmacol Toxicol 2002, 90: 139-43.
29. Goldstein, J.L., Ho, Y.K., Basu, S.K, Brown, M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979, 76: 333-7.